90 related articles for article (PubMed ID: 2982489)
21. Cyclic adenosine 3':5'-monophosphate-dependent and -independent protein kinase in acute myeloblastic leukemia.
Elias L; Li AP; Longmire J
Cancer Res; 1981 Jun; 41(6):2182-8. PubMed ID: 6263462
[TBL] [Abstract][Full Text] [Related]
22. Calmodulin sensitive phosphodiesterase of porcine cerebral cortex: kinetic behavior, calmodulin activation, and stability.
Keravis TM; Duemler BH; Wells JN
J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(5):365-72. PubMed ID: 3040819
[TBL] [Abstract][Full Text] [Related]
23. The insulin- and glucagon-stimulated 'dense-vesicle' high-affinity cyclic AMP phosphodiesterase from rat liver. Purification, characterization and inhibitor sensitivity.
Pyne NJ; Cooper ME; Houslay MD
Biochem J; 1987 Feb; 242(1):33-42. PubMed ID: 3036087
[TBL] [Abstract][Full Text] [Related]
24. Partial purification and characterization of adenosine- and guanosine-3',5'-monophosphate phosphodiesterases from human lung tissue.
Bergstrand H; Lundquist B
Biochemistry; 1976 Apr; 15(8):1727-35. PubMed ID: 178354
[TBL] [Abstract][Full Text] [Related]
25. Purification of an insulin-sensitive cyclic AMP phosphodiesterase from rat liver.
Boyes S; Loten EG
Eur J Biochem; 1988 Jun; 174(2):303-9. PubMed ID: 2838272
[TBL] [Abstract][Full Text] [Related]
26. Properties of hepatic and pancreatic cyclic AMP phosphodiesterase in the cat.
Sakane Y; Morgan PR; Glenn TM
Res Commun Chem Pathol Pharmacol; 1981 Nov; 34(2):251-66. PubMed ID: 6278552
[TBL] [Abstract][Full Text] [Related]
27. [Multiple forms of cyclic nucleotide phosphotransferases in mouse thymocytes].
Rybalkin SD; Kurennaia GS; Sobolev AS
Biokhimiia; 1984 Dec; 49(12):1927-33. PubMed ID: 6098315
[TBL] [Abstract][Full Text] [Related]
28. Purification and properties of the insulin-stimulated cyclic AMP phosphodiesterase from rat liver plasma membranes.
Marchmont RJ; Ayad SR; Houslay MD
Biochem J; 1981 Jun; 195(3):645-52. PubMed ID: 6274308
[TBL] [Abstract][Full Text] [Related]
29. A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
Alvarez R; Banerjee GL; Bruno JJ; Jones GL; Littschwager K; Strosberg AM; Venuti MC
Mol Pharmacol; 1986 Jun; 29(6):554-60. PubMed ID: 3012320
[TBL] [Abstract][Full Text] [Related]
30. Detailed characterization of a purified type 4 phosphodiesterase, HSPDE4B2B: differentiation of high- and low-affinity (R)-rolipram binding.
Rocque WJ; Holmes WD; Patel IR; Dougherty RW; Ittoop O; Overton L; Hoffman CR; Wisely GB; Willard DH; Luther MA
Protein Expr Purif; 1997 Mar; 9(2):191-202. PubMed ID: 9056484
[TBL] [Abstract][Full Text] [Related]
31. [Properties of cyclic nucleotide phosphodiesterase of the rabbit myometrium in various functional states].
Kurskiĭ MD; Osipenko AA; Prishchepa LA
Biokhimiia; 1984 Jul; 49(7):1096-102. PubMed ID: 6089916
[TBL] [Abstract][Full Text] [Related]
32. Cyclic nucleotide phosphodiesterase activities in Neurospora crassa.
Téllez-Iñón MT; Glikin GC; Torres HN
Biochem J; 1982 Jun; 203(3):611-6. PubMed ID: 6288007
[TBL] [Abstract][Full Text] [Related]
33. Higher-plant cyclic nucleotide phosphodiesterases. Resolution, partial purification and properties of three phosphodiesterases from potato tuber.
Ashton AR; Polya GM
Biochem J; 1975 Aug; 149(2):329-39. PubMed ID: 241333
[TBL] [Abstract][Full Text] [Related]
34. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
Weishaar RE; Quade MM; Schenden JA; Evans DB
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170
[TBL] [Abstract][Full Text] [Related]
35. Purification and characterization of human lung calmodulin-independent cyclic AMP phosphodiesterase.
Moore JB; Schroedter DE
Arch Biochem Biophys; 1982 Jan; 213(1):276-87. PubMed ID: 6277253
[No Abstract] [Full Text] [Related]
36. Characterisation of cyclic adenosine 3':5'-monophosphate phospodiesterase from Walker carcinoma sensitive and resistant to bifunctional alkylating agents.
Tisdale MJ
Biochim Biophys Acta; 1975 Jul; 397(1):134-43. PubMed ID: 238630
[TBL] [Abstract][Full Text] [Related]
37. Identification and stabilization of large molecular weight PDE-IVs from U937 cells.
DiSanto ME; Heaslip RJ
Biochem Biophys Res Commun; 1993 Dec; 197(3):1126-31. PubMed ID: 8280127
[TBL] [Abstract][Full Text] [Related]
38. Purification, properties and polyclonal antibodies for the particulate, low Km cAMP phosphodiesterase from bovine adipose tissue.
Degerman E; Manganiello VC; Newman AH; Rice KC; Belfrage P
Second Messengers Phosphoproteins; 1988; 12(4):171-82. PubMed ID: 2854560
[TBL] [Abstract][Full Text] [Related]
39. The cyclic adenosine monophosphate phosphodiesterases of myoblasts, fibroblasts, and their somatic cell hybrids.
Ball EH; Narindrasorasak S; Sanwal BD
Can J Biochem; 1979 Oct; 57(10):1220-8. PubMed ID: 231992
[TBL] [Abstract][Full Text] [Related]
40. Regulation of cyclic nucleotide phosphodiesterase activity.
Vaughan M; Danello MA; Manganiello VC; Strewler GJ
Adv Cyclic Nucleotide Res; 1981; 14():263-71. PubMed ID: 6169258
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
